{"entity":{"type":"insider","cik":"0001657719","url":"/insider/0001657719","json_url":"/insider/0001657719.json","name":"Watson David O.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":40,"n_filings":31,"first":"2018-09-17","last":"2026-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Watson David O.","source":"filing","n_filings":31,"first_seen":"2018-09-17","last_seen":"2026-01-23"}],"transactions":[{"id":5834236,"accession":"0001492422-26-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000054","line_url":"/filing/0001492422-26-000054#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7832.0,"shares_display":"7,832","price_per_share":21.7654,"price_display":"21.77","price_state":"stated","total_value":170466.6128,"total_display":"170,466.61","total_whole":"170,467","shares_owned_after":88531.0,"shares_owned_after_display":"88,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-23","scope":"insider"},{"id":5881416,"accession":"0001492422-26-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000038","line_url":"/filing/0001492422-26-000038#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2475.0,"shares_display":"2,475","price_per_share":19.7929,"price_display":"19.79","price_state":"stated","total_value":48987.4275,"total_display":"48,987.43","total_whole":"48,987","shares_owned_after":96363.0,"shares_owned_after_display":"96,363","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-21","scope":"insider"},{"id":6021524,"accession":"0001492422-26-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-26-000025","line_url":"/filing/0001492422-26-000025#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5780.0,"shares_display":"5,780","price_per_share":22.1872,"price_display":"22.19","price_state":"stated","total_value":128242.016,"total_display":"128,242.02","total_whole":"128,242","shares_owned_after":98838.0,"shares_owned_after_display":"98,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-15","scope":"insider"},{"id":4040700,"accession":"0001492422-25-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-25-000014","line_url":"/filing/0001492422-25-000014#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.49,"price_display":"24.49","price_state":"stated","total_value":122450.0,"total_display":"122,450.00","total_whole":"122,450","shares_owned_after":103730.0,"shares_owned_after_display":"103,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-16","filed_date":"2025-12-18","scope":"insider"},{"id":4965235,"accession":"0001492422-25-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-25-000012","line_url":"/filing/0001492422-25-000012#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.06,"price_display":"20.06","price_state":"stated","total_value":100300.0,"total_display":"100,300.00","total_whole":"100,300","shares_owned_after":108730.0,"shares_owned_after_display":"108,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-18","scope":"insider"},{"id":4648673,"accession":"0001492422-25-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-25-000009","line_url":"/filing/0001492422-25-000009#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.22,"price_display":"25.22","price_state":"stated","total_value":126100.0,"total_display":"126,100.00","total_whole":"126,100","shares_owned_after":113730.0,"shares_owned_after_display":"113,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-16","filed_date":"2025-10-17","scope":"insider"},{"id":4151987,"accession":"0001492422-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001492422-25-000007","line_url":"/filing/0001492422-25-000007#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.34,"price_display":"24.34","price_state":"stated","total_value":121700.0,"total_display":"121,700.00","total_whole":"121,700","shares_owned_after":118730.0,"shares_owned_after_display":"118,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-16","filed_date":"2025-09-18","scope":"insider"},{"id":4270533,"accession":"0001193125-25-202168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-202168","line_url":"/filing/0001193125-25-202168#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":26.17,"price_display":"26.17","price_state":"stated","total_value":523400.0,"total_display":"523,400.00","total_whole":"523,400","shares_owned_after":50136.0,"shares_owned_after_display":"50,136","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-10","filed_date":"2025-09-12","scope":"insider"},{"id":5023969,"accession":"0001127602-25-020714","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-020714","line_url":"/filing/0001127602-25-020714#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":27.8,"price_display":"27.80","price_state":"stated","total_value":139000.0,"total_display":"139,000.00","total_whole":"139,000","shares_owned_after":123730.0,"shares_owned_after_display":"123,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-18","filed_date":"2025-08-19","scope":"insider"},{"id":4170226,"accession":"0001127602-25-019411","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-019411","line_url":"/filing/0001127602-25-019411#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":19.55,"price_display":"19.55","price_state":"stated","total_value":97750.0,"total_display":"97,750.00","total_whole":"97,750","shares_owned_after":128730.0,"shares_owned_after_display":"128,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-16","filed_date":"2025-07-18","scope":"insider"},{"id":4350223,"accession":"0001127602-25-017714","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-017714","line_url":"/filing/0001127602-25-017714#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":18.77,"price_display":"18.77","price_state":"stated","total_value":93850.0,"total_display":"93,850.00","total_whole":"93,850","shares_owned_after":133730.0,"shares_owned_after_display":"133,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-16","filed_date":"2025-06-18","scope":"insider"},{"id":4099873,"accession":"0000950170-25-034908","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-034908","line_url":"/filing/0000950170-25-034908#line-3","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5569.0,"shares_display":"5,569","price_per_share":25.1013,"price_display":"25.10","price_state":"stated","total_value":139789.1397,"total_display":"139,789.14","total_whole":"139,789","shares_owned_after":138730.0,"shares_owned_after_display":"138,730","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider"},{"id":4064840,"accession":"0001127602-25-002389","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-002389","line_url":"/filing/0001127602-25-002389#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":695.0,"shares_display":"695","price_per_share":29.5236,"price_display":"29.52","price_state":"stated","total_value":20518.902,"total_display":"20,518.90","total_whole":"20,519","shares_owned_after":144299.0,"shares_owned_after_display":"144,299","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-29","filed_date":"2025-01-30","scope":"insider"},{"id":4141988,"accession":"0001127602-25-001847","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001847","line_url":"/filing/0001127602-25-001847#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3323.0,"shares_display":"3,323","price_per_share":30.4255,"price_display":"30.43","price_state":"stated","total_value":101103.9365,"total_display":"101,103.94","total_whole":"101,104","shares_owned_after":144994.0,"shares_owned_after_display":"144,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-22","filed_date":"2025-01-23","scope":"insider"},{"id":5044802,"accession":"0001127602-25-001631","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001631","line_url":"/filing/0001127602-25-001631#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2201.0,"shares_display":"2,201","price_per_share":29.9582,"price_display":"29.96","price_state":"stated","total_value":65937.9982,"total_display":"65,938.00","total_whole":"65,938","shares_owned_after":105555.0,"shares_owned_after_display":"105,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-21","scope":"insider"},{"id":4800997,"accession":"0001127602-25-001204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-25-001204","line_url":"/filing/0001127602-25-001204#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4965.0,"shares_display":"4,965","price_per_share":28.7021,"price_display":"28.70","price_state":"stated","total_value":142505.9265,"total_display":"142,505.93","total_whole":"142,506","shares_owned_after":107756.0,"shares_owned_after_display":"107,756","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-14","scope":"insider"},{"id":2774189,"accession":"0000950170-24-136202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-136202","line_url":"/filing/0000950170-24-136202#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":34.235,"price_display":"34.24","price_state":"stated","total_value":171175.0,"total_display":"171,175.00","total_whole":"171,175","shares_owned_after":112721.0,"shares_owned_after_display":"112,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-13","scope":"insider"},{"id":2346089,"accession":"0001127602-24-004737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-004737","line_url":"/filing/0001127602-24-004737#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":781.0,"shares_display":"781","price_per_share":67.7669,"price_display":"67.77","price_state":"stated","total_value":52925.9489,"total_display":"52,925.95","total_whole":"52,926","shares_owned_after":103390.0,"shares_owned_after_display":"103,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":2108750,"accession":"0001127602-24-002755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-002755","line_url":"/filing/0001127602-24-002755#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":906.0,"shares_display":"906","price_per_share":64.1382,"price_display":"64.14","price_state":"stated","total_value":58109.2092,"total_display":"58,109.21","total_whole":"58,109","shares_owned_after":104171.0,"shares_owned_after_display":"104,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-31","scope":"insider"},{"id":2721505,"accession":"0001127602-24-001963","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-24-001963","line_url":"/filing/0001127602-24-001963#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4184.0,"shares_display":"4,184","price_per_share":64.996,"price_display":"65.00","price_state":"stated","total_value":271943.264,"total_display":"271,943.26","total_whole":"271,943","shares_owned_after":105077.0,"shares_owned_after_display":"105,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-23","scope":"insider"},{"id":2171803,"accession":"0001127602-24-001436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-24-001436","line_url":"/filing/0001127602-24-001436#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4240.0,"shares_display":"4,240","price_per_share":66.8086,"price_display":"66.81","price_state":"stated","total_value":283268.464,"total_display":"283,268.46","total_whole":"283,268","shares_owned_after":109261.0,"shares_owned_after_display":"109,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-17","scope":"insider"},{"id":8149438,"accession":"0001127602-23-030172","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-23-030172","line_url":"/filing/0001127602-23-030172","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3905.0,"shares_display":"3,905","price_per_share":57.227091037131885,"price_display":"57.23","price_state":"stated","total_value":223471.7905,"total_display":"223,471.79","total_whole":"223,472","shares_owned_after":89753.0,"shares_owned_after_display":"89,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-19","filed_date":"2023-12-20","scope":"insider","n_lines":2},{"id":7845919,"accession":"0001127602-23-020395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-23-020395","line_url":"/filing/0001127602-23-020395#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8510.0,"shares_display":"8,510","price_per_share":89.98,"price_display":"89.98","price_state":"stated","total_value":765729.8,"total_display":"765,729.80","total_whole":"765,730","shares_owned_after":85753.0,"shares_owned_after_display":"85,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider"},{"id":6270346,"accession":"0001127602-22-018041","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-018041","line_url":"/filing/0001127602-22-018041#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":44.514,"price_display":"44.51","price_state":"stated","total_value":445140.0,"total_display":"445,140.00","total_whole":"445,140","shares_owned_after":115569.0,"shares_owned_after_display":"115,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-22","filed_date":"2022-06-23","scope":"insider"},{"id":6885574,"accession":"0001127602-22-012574","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-012574","line_url":"/filing/0001127602-22-012574#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":125569.0,"shares_owned_after_display":"125,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-25","filed_date":"2022-04-27","scope":"insider"},{"id":4780016,"accession":"0001127602-21-031970","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-21-031970","line_url":"/filing/0001127602-21-031970#line-1","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":48.5,"price_display":"48.50","price_state":"stated","total_value":58200.0,"total_display":"58,200.00","total_whole":"58,200","shares_owned_after":107534.0,"shares_owned_after_display":"107,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-28","scope":"insider"},{"id":4780002,"accession":"0001127602-21-031868","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001127602-21-031868","line_url":"/filing/0001127602-21-031868","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10571.0,"shares_display":"10,571","price_per_share":47.80745615362785,"price_display":"47.81","price_state":"stated","total_value":505372.619,"total_display":"505,372.62","total_whole":"505,373","shares_owned_after":104019.0,"shares_owned_after_display":"104,019","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-23","scope":"insider","n_lines":3},{"id":3336122,"accession":"0001127602-20-031348","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001127602-20-031348","line_url":"/filing/0001127602-20-031348","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8398.0,"shares_display":"8,398","price_per_share":52.05971421767087,"price_display":"52.06","price_state":"stated","total_value":437197.48,"total_display":"437,197.48","total_whole":"437,197","shares_owned_after":49093.0,"shares_owned_after_display":"49,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-15","scope":"insider","n_lines":6},{"id":3336079,"accession":"0001127602-20-031348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-031348","line_url":"/filing/0001127602-20-031348#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9935.0,"shares_display":"9,935","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":496750.0,"total_display":"496,750.00","total_whole":"496,750","shares_owned_after":43404.0,"shares_owned_after_display":"43,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-11","filed_date":"2020-12-15","scope":"insider"},{"id":2777531,"accession":"0000899243-20-004260","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-004260","line_url":"/filing/0000899243-20-004260#line-3","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":44.5,"price_display":"44.50","price_state":"stated","total_value":222500.0,"total_display":"222,500.00","total_whole":"222,500","shares_owned_after":35417.0,"shares_owned_after_display":"35,417","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-12","scope":"insider"},{"id":3329416,"accession":"0001127602-20-002514","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-002514","line_url":"/filing/0001127602-20-002514#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":40.467,"price_display":"40.47","price_state":"stated","total_value":121401.0,"total_display":"121,401.00","total_whole":"121,401","shares_owned_after":19042.0,"shares_owned_after_display":"19,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-01-28","scope":"insider"},{"id":6038557,"accession":"0000899243-18-024601","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-024601","line_url":"/filing/0000899243-18-024601#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001657719","owner_name":"Watson David O.","owner_display_name":"Watson David O.","owner_url":"/insider/0001657719","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15776.0,"shares_display":"15,776","price_per_share":18.784,"price_display":"18.78","price_state":"stated","total_value":296336.384,"total_display":"296,336.38","total_whole":"296,336","shares_owned_after":17042.0,"shares_owned_after_display":"17,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-14","filed_date":"2018-09-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":40,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":40,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":40},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Officer (General Counsel)","n_filings":31,"first_seen":"2018-09-17","last_seen":"2026-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001657719","retrieved_at":"2026-08-24T22:03:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}